Brief: Oncolys BioPharma signs exclusive license agreement with Jiangsu Hengrui Medicine on OBP-301 in China

Oncolys Biopharma

30/11/2016 09:16

Nov 30 (Reuters) - Oncolys BioPharma Inc  4588.T  : 
     
    * Says co enters into exclusive license agreement with 
Jiangsu Hengrui Medicine Co Ltd for OBP-301, valid in China 
mainland, Hong Kong and Macao   
    * Previous plan was disclosed on May 20 
     
    Source text in Japanese: https://goo.gl/7PYLBq 
    Further company coverage: 4588.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))